Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probenecid Boosting for HIV PrEP
NCT03202511Phase 1Completed
- Sponsor
- Indiana University
- Start
- Jun 2017
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of probenecid in human immunodeficiency virus infection (HIV), sponsored by Indiana University. Primary endpoint: Plasma Tenofovir Area Under the Curve from 0 to Infinity Geometric Mean Ratio at 72 hours. Started Jun 2017; status: completed.
02
Drugs
probenecid
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03202511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03202511.